Evnia ApS

Evnia ApS is a Danish consultancy specializing in regulatory and clinical affairs for the biotechnology sector. The company supports biotech companies by providing strategic guidance across the full product lifecycle—from early development through clinical trials to regulatory approval and post-market compliance.

With deep expertise in EU and international regulatory frameworks, Evnia helps clients navigate complex requirements in Europe and USA.

Evnia’s services include regulatory strategy development, clinical trial design and oversight, Post Market Clinical Follow ups, preparation of regulatory submissions . The firm works closely with biotech startups, scale-ups, and established companies to ensure that their products meet the highest standards of safety, efficacy, and regulatory integrity.

By combining scientific insight with regulatory precision, Evnia enables its clients to accelerate development timelines, reduce risk, and achieve successful market entry. The company is committed to fostering innovation in life sciences by acting as a trusted partner in regulatory and clinical excellence.

Evnia ApS stands out for its tailored, hands-on approach and its ability to translate complex regulatory challenges into actionable strategies that drive biotech growth and patient impact.